EDIT
Price
$2.25
Change
+$0.05 (+2.27%)
Updated
Jul 1, 04:59 PM (EDT)
Capitalization
184.17M
29 days until earnings call
RVMD
Price
$38.11
Change
+$1.32 (+3.59%)
Updated
Jul 1, 02:51 PM (EDT)
Capitalization
6.85B
36 days until earnings call
Interact to see
Advertisement

EDIT vs RVMD

Header iconEDIT vs RVMD Comparison
Open Charts EDIT vs RVMDBanner chart's image
Editas Medicine
Price$2.25
Change+$0.05 (+2.27%)
Volume$23.04K
Capitalization184.17M
Revolution Medicines
Price$38.11
Change+$1.32 (+3.59%)
Volume$1.77K
Capitalization6.85B
EDIT vs RVMD Comparison Chart in %
Loading...
EDIT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RVMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EDIT vs. RVMD commentary
Jul 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EDIT is a Hold and RVMD is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 01, 2025
Stock price -- (EDIT: $2.20 vs. RVMD: $36.79)
Brand notoriety: EDIT and RVMD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EDIT: 107% vs. RVMD: 105%
Market capitalization -- EDIT: $184.17M vs. RVMD: $6.85B
EDIT [@Biotechnology] is valued at $184.17M. RVMD’s [@Biotechnology] market capitalization is $6.85B. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EDIT’s FA Score shows that 0 FA rating(s) are green whileRVMD’s FA Score has 0 green FA rating(s).

  • EDIT’s FA Score: 0 green, 5 red.
  • RVMD’s FA Score: 0 green, 5 red.
According to our system of comparison, EDIT is a better buy in the long-term than RVMD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EDIT’s TA Score shows that 2 TA indicator(s) are bullish while RVMD’s TA Score has 3 bullish TA indicator(s).

  • EDIT’s TA Score: 2 bullish, 4 bearish.
  • RVMD’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both EDIT and RVMD are a bad buy in the short-term.

Price Growth

EDIT (@Biotechnology) experienced а +4.76% price change this week, while RVMD (@Biotechnology) price change was -8.12% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.51%. For the same industry, the average monthly price growth was +32.88%, and the average quarterly price growth was +3.93%.

Reported Earning Dates

EDIT is expected to report earnings on Jul 30, 2025.

RVMD is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (-0.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RVMD($6.86B) has a higher market cap than EDIT($184M). EDIT YTD gains are higher at: 73.228 vs. RVMD (-15.889). EDIT has higher annual earnings (EBITDA): -244.52M vs. RVMD (-776.65M). RVMD has more cash in the bank: 2.1B vs. EDIT (221M). EDIT has less debt than RVMD: EDIT (31.1M) vs RVMD (134M). EDIT has higher revenues than RVMD: EDIT (35.8M) vs RVMD (0).
EDITRVMDEDIT / RVMD
Capitalization184M6.86B3%
EBITDA-244.52M-776.65M31%
Gain YTD73.228-15.889-461%
P/E RatioN/AN/A-
Revenue35.8M0-
Total Cash221M2.1B11%
Total Debt31.1M134M23%
FUNDAMENTALS RATINGS
EDIT: Fundamental Ratings
EDIT
OUTLOOK RATING
1..100
68
VALUATION
overvalued / fair valued / undervalued
1..100
38
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
EDITRVMD
RSI
ODDS (%)
Bearish Trend 2 days ago
83%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
75%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 22 days ago
76%
Bullish Trend 30 days ago
80%
Declines
ODDS (%)
N/A
Bearish Trend 2 days ago
77%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
82%
Aroon
ODDS (%)
Bullish Trend 2 days ago
78%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
EDIT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RVMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TMCJX48.89N/A
N/A
Touchstone Mid Cap C
EKJFX14.52N/A
N/A
Allspring Premier Large Co Gr R6
AFCHX17.39N/A
N/A
American Century Focused Intl Gr C
FCENX13.86N/A
N/A
Franklin International Core Equity Adv
TISDX11.98N/A
N/A
Transamerica Intl Sust Eq A

EDIT and

Correlation & Price change

A.I.dvisor indicates that over the last year, EDIT has been loosely correlated with CRSP. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if EDIT jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EDIT
1D Price
Change %
EDIT100%
-3.51%
CRSP - EDIT
54%
Loosely correlated
+4.15%
AXON - EDIT
52%
Loosely correlated
+1.14%
VCYT - EDIT
49%
Loosely correlated
-1.28%
PRME - EDIT
48%
Loosely correlated
+2.07%
SLDB - EDIT
48%
Loosely correlated
+3.18%
More

RVMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, RVMD has been loosely correlated with ERAS. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if RVMD jumps, then ERAS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RVMD
1D Price
Change %
RVMD100%
-0.33%
ERAS - RVMD
57%
Loosely correlated
-3.05%
CRNX - RVMD
55%
Loosely correlated
-4.01%
KYMR - RVMD
54%
Loosely correlated
-1.09%
RARE - RVMD
52%
Loosely correlated
-0.44%
NRIX - RVMD
51%
Loosely correlated
-2.15%
More